原位腺癌的诊断与治疗策略进展
[Advance in Diagnose and Treatment Strategies of Adenocarcinoma in Situ].
作者信息
Qiu Yangbo, Shen-Tu Yang
机构信息
Shanghai Chest Hospital, Shanghai Jiaotong University, Department of Thoracic Surgery, Shanghai Lung Tumor Clinical Medical Center, Shanghai 200039, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2017 Sep 20;20(9):641-644. doi: 10.3779/j.issn.1009-3419.2017.09.09.
Abstract
Adenocarcinoma in situ (AIS) is a new concept which was introduced to the 2011 The International Association for the Study of Cancer (IASLC)/ American Thoracic Society (ATS)/ European Respiratory Society (ERS) International Multidisciplinary Classification of Lung Adenocarcinoma firstly and an important supplement of The 2015 World Health Organization Classification of Lung Tumors. Because AIS is at an early stage of development of lung adenocarcinoma, the deepening understanding of its pathology, differential diagnosis, treatment strategies, has an important significance for the improvement of the prognosis of lung adenocarcinoma. This review will provide a systematic review of the main progress of occurrence and development, pathological characteristics, differential diagnosis and treatment strategy of AIS, in order to provide theoretical basis for the further research of AIS.
摘要
原位腺癌（AIS）是一个新的概念，它首先被引入到2011年国际肺癌研究协会（IASLC）/美国胸科学会（ATS）/欧洲呼吸学会（ERS）国际多学科肺腺癌分类中，是2015年世界卫生组织肺肿瘤分类的重要补充。由于AIS处于肺腺癌发展的早期阶段，深入了解其病理学、鉴别诊断、治疗策略，对改善肺腺癌的预后具有重要意义。本文将对AIS的发生发展、病理特征、鉴别诊断及治疗策略的主要进展进行系统综述，以便为AIS的进一步研究提供理论依据。
相似文献
1
[Advance in Diagnose and Treatment Strategies of Adenocarcinoma in Situ].原位腺癌的诊断与治疗策略进展
Zhongguo Fei Ai Za Zhi. 2017 Sep 20;20(9):641-644. doi: 10.3779/j.issn.1009-3419.2017.09.09.
2
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.采用2011年国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类系统对肺腺癌进行分期：原位腺癌和微浸润腺癌的汇总分析
Clin Lung Cancer. 2016 Sep;17(5):e57-e64. doi: 10.1016/j.cllc.2016.03.009. Epub 2016 Mar 30.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.基于组织的免疫组化生物标志物在子宫颈恶性腺性病变诊断中的准确性：文献系统评价与Meta分析
Int J Gynecol Pathol. 2017 Jul;36(4):310-322. doi: 10.1097/PGP.0000000000000345.
5
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study.外周血单个核细胞的多部位DNA甲基化改变作为早期侵袭性肺腺癌/Ⅰ期肺腺癌诊断的新型生物标志物：一项多中心队列研究
Int J Surg. 2025 Jan 1;111(1):40-54. doi: 10.1097/JS9.0000000000002101.
6
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.酪氨酸激酶抑制剂治疗后发生小细胞肺癌转化的肺腺癌患者的结局：系统评价和汇总分析。
Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中，如果患者出现以下症状和体征，可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗：一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Hormonal therapies for early breast cancer: systematic review and economic evaluation.早期乳腺癌的激素疗法：系统评价与经济学评估
Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. doi: 10.3310/hta11260.
10
A systematic overview of chemotherapy effects in non-small cell lung cancer.非小细胞肺癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):327-39. doi: 10.1080/02841860151116402.
引用本文的文献
1
Treatment options and prognosis of patients with lung squamous cell cancer in situ: a comparative study of lung adenocarcinoma in situ and stage IA lung squamous cell cancer.原位肺鳞状细胞癌患者的治疗选择与预后：原位肺腺癌与ⅠA期肺鳞状细胞癌的比较研究
Transl Lung Cancer Res. 2023 Jun 30;12(6):1276-1292. doi: 10.21037/tlcr-23-243. Epub 2023 Jun 12.
2
Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study.吉非替尼联合培美曲塞/铂类治疗晚期表皮生长因子受体（EGFR）突变肺腺癌患者的疗效与安全性：一项真实世界观察性研究
Onco Targets Ther. 2022 Jan 13;15:31-39. doi: 10.2147/OTT.S332998. eCollection 2022.
本文引用的文献
1
Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.IA期肺腺癌的孤立性磨玻璃密度结节：18F-FDG PET/CT与高分辨率计算机断层扫描特征相结合预测浸润性腺癌
Oncotarget. 2017 Apr 4;8(14):23312-23321. doi: 10.18632/oncotarget.15577.
2
Radiological prediction of tumor invasiveness of lung adenocarcinoma on thin-section CT.薄层CT对肺腺癌肿瘤侵袭性的放射学预测
Medicine (Baltimore). 2017 Mar;96(11):e6331. doi: 10.1097/MD.0000000000006331.
3
Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity.肺局灶性间质纤维化、非典型腺瘤样增生、原位腺癌及纯磨玻璃密度微浸润腺癌的薄层计算机断层扫描与组织病理学比较
Eur J Radiol. 2016 Oct;85(10):1708-1715. doi: 10.1016/j.ejrad.2016.07.012. Epub 2016 Jul 18.
4
Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.肺原位腺癌向微浸润性腺癌及浸润性贴壁为主型腺癌进展过程中的微环境变化。
Lung Cancer. 2016 Oct;100:53-62. doi: 10.1016/j.lungcan.2016.07.024. Epub 2016 Jul 27.
5
Lung Adenocarcinoma: Correlation of Quantitative CT Findings with Pathologic Findings.肺腺癌：定量 CT 表现与病理结果的相关性。
Radiology. 2016 Sep;280(3):931-9. doi: 10.1148/radiol.2016142975. Epub 2016 Apr 20.
6
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
7
Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.原位腺癌和微浸润腺癌患者淋巴结受累的预后及状况——一项系统文献综述和汇总数据分析
J Thorac Dis. 2015 Nov;7(11):2003-9. doi: 10.3978/j.issn.2072-1439.2015.11.48.
8
HRCT features distinguishing pre-invasive from invasive pulmonary adenocarcinomas appearing as ground-glass nodules.高分辨率CT（HRCT）特征可区分表现为磨玻璃结节的浸润前与浸润性肺腺癌。
Eur Radiol. 2016 Sep;26(9):2921-8. doi: 10.1007/s00330-015-4131-3. Epub 2015 Dec 11.
9
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类：自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
10
High-resolution computed tomography findings of early mucinous adenocarcinomas and their pathologic characteristics in 22 surgically resected cases.22例手术切除的早期黏液腺癌的高分辨率计算机断层扫描结果及其病理特征
Eur J Radiol. 2015 May;84(5):993-7. doi: 10.1016/j.ejrad.2015.01.014. Epub 2015 Jan 28.
Zotero 插件